- Home
- EIC vs AMRN Comparison
EIC vs AMRN Comparison
Compare EIC & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EIC | AMRN |
|---|---|---|
| Founded | N/A | 1989 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 223.3M | 339.8M |
| IPO Year | N/A | 1998 |
Fundamental Metrics
Financial Performance| Metric | EIC | AMRN |
|---|---|---|
| Price | $9.42 | $14.11 |
| Analyst Decision | Strong Buy | Strong Sell |
| Analyst Count | 3 | 1 |
| Target Price | ★ $12.63 | $12.00 |
| AVG Volume (30 Days) | ★ 173.4K | 60.9K |
| Earning Date | 02-26-2026 | 05-06-2026 |
| Dividend Yield | ★ 14.33% | N/A |
| EPS Growth | N/A | ★ 55.00 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $181,104,000.00 |
| Revenue This Year | $0.37 | N/A |
| Revenue Next Year | $1.08 | $1.26 |
| P/E Ratio | $9.08 | ★ N/A |
| Revenue Growth | N/A | ★ 39.22 |
| 52 Week Low | $9.17 | $0.39 |
| 52 Week High | $15.20 | $20.90 |
Technical Indicators
Market Signals| Indicator | EIC | AMRN |
|---|---|---|
| Relative Strength Index (RSI) | 41.05 | 44.77 |
| Support Level | $9.25 | $13.63 |
| Resistance Level | $10.15 | $14.55 |
| Average True Range (ATR) | 0.17 | 0.69 |
| MACD | 0.02 | -0.10 |
| Stochastic Oscillator | 41.82 | 18.46 |
Price Performance
Historical ComparisonAbout EIC Eagle Point Income Company Inc.
Eagle Point Income Co Inc is a closed-end management investment company. Its primary investment objective is to generate high current income, with a secondary objective to generate capital appreciation. The Company seeks to achieve its investment objectives by investing in junior debt tranches of collateralized loan obligations, or "CLOs," that are collateralized by a portfolio consisting of below-investment grade U.S. senior secured loans with a large number of distinct underlying borrowers across various industry sectors.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.